Market Segmentation
- India Oncology NGS Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Whole Genome Sequencing
- Whole Exome Sequencing
- Targeted & Gene Panel Sequencing
- Amplicon-based
- Hybridization-based
- India Oncology NGS Application Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostics and Screening
- Screening
- Sporadic Cancer
- Inherited Cancer
- Companion Diagnostics
- Other Diagnostics
- Screening
- Research Studies
- Diagnostics and Screening
- India Oncology NGS Product & Service Outlook (Revenue, USD Million, 2018 - 2030)
- Platforms and Related Products
- Panels
- Consumables
- Platforms
- Services
- Platforms and Related Products
- India Oncology NGS Workflow Outlook (Revenue, USD Million, 2018 - 2030)
- Pre-Sequencing
- NGS Library Preparation Kits
- Semi-automated Library Preparation
- Automated Library Preparation
- Clonal Amplification
- Sequencing
- NGS Data Analysis
- NGS Primary Data Analysis
- NGS Secondary Data Analysis
- NGS Tertiary Data Analysis
- Pre-Sequencing
- India Oncology NGS End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other users
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
